Leo Grünstein

Leo Grünstein has extensive work experience in various roles and industries. Leo is the Founder & CEO of Spiden, a company focused on continuous monitoring of biomarkers and drugs in blood and bodily fluids to unlock longevity and preventative medicine. Leo also co-founded Caeli Nova and served as a board member.

Leo is the Chairman of LG Capital AG, a family office holding company where they focus on asset management, company building/incubating, and startup investments. Leo has successfully incubated over 20 ventures across 10 countries, raised over $500 million for startup companies, and achieved successful exits for more than 10 ventures within the portfolio.

Additionally, Leo co-founded MoneyPark, Switzerland's leading tech-enabled financial intermediary, where they served as a board member. The company was acquired by Helvetia Insurance in 2016 for a valuation of 153 million CHF. Leo had a full exit from MoneyPark in 2019 through LG Capital.

Leo's earlier experience includes working as an Engagement Manager at McKinsey & Company and a Summer Associate at Booz & Company. Leo also worked as an M&A Investment Banking Analyst at HSBC.

Overall, Leo Grünstein's work experience demonstrates their expertise in entrepreneurship, asset management, financial intermediation, and consulting.

Leo Grünstein completed their Bachelor's degree in Business Administration from the University of St.Gallen, where they studied from 2004 to 2007. Later, they pursued a Master's in Business Administration (M.B.A.) at Columbia Business School from 2008 to 2010.